Fresenius

FRE · Xetra · EUR

€43.63Change from previous close: −0.38%Absolute change: −€0.17

Close · October 2, 2026

At a glance

Revenue growth
+4.19%
2025 vs 2024
Net income growth
+168.37%
2025 vs 2024
Net margin
5.5%
2024: 2.1%

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue22,87321,95421,06721,532—
Cost of revenue17,18016,31716,09616,129—
Gross profit5,6935,6374,9715,403—
Selling, general and administrative2,8832,8883,0273,094—
Research and development633641661639—
Operating income2,1812,0731,1831,812—
EBIT2,6332,2341,2921,942—
EBITDA3,7533,4732,6923,099—
Interest expense445552519345—
Pre-tax income2,1881,6827731,597—
Income tax582530485375—
Net income1,264471-5941,372—
Net income to common shareholders1,264471-5941,372—
Basic EPS2.240.84-1.052.44—
Diluted EPS2.240.84-1.052.44—
Average shares (basic)563563563561—
Average shares (diluted)563563563561—